@article{a5bc412561ab465aa5c75d0c8c871cb9,
title = "Detection of adamantane-sensitive influenza A(H3N2) viruses in Australia, 2017: A cause for hope?",
abstract = "For over a decade virtually all A(H3N2) influenza viruses have been resistant to the adamantane class of antivirals. However, during the 2017 influenza season in Australia, 15/461 (3.3%) adamantane-sensitive A(H3N2) viruses encoding serine at residue 31 of the M2 protein were detected, more than the total number identified globally during the last 6 years. A return to wide circulation of adamantane-sensitive A(H3N2) viruses would revive the option of using these drugs for treatment and prophylaxis.",
author = "Aeron Hurt and Naomi Komadina and Deng, {Yi Mo} and Matthew Kaye and Sheena Sullivan and Kanta Subbarao and Ian Barr",
note = "Funding Information: The authors wish to acknowledge the contribution of colleagues in the World Health Organization (WHO) Collaborating Centre for Reference and Research on Influenza, Melbourne for conducting virus isolation and to the laboratories in the WHO Global Influenza Surveillance and Response System (GISRS) for the submission of influenza specimens or isolates to the Collaborating Centre. The authors also acknowledge the originating and submitting laboratories that provided sequences to GISAID{\textquoteright}s EpiFlu{\texttrademark} Data base which were used to calculate the global frequencies of A(H3N2) viruses with different amino acid residues of at position 31 of the M2 (www.gisaid.org). The WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health. Publisher Copyright: {\textcopyright} The authors, 2017.",
year = "2017",
month = nov,
day = "23",
doi = "10.2807/1560-7917.ES.2017.22.47.17-00731",
language = "English",
volume = "22",
journal = "Eurosurveillance",
issn = "1025-496X",
publisher = "European Centre for Disease Prevention and Control",
number = "47",
}
